Literature DB >> 7990905

Brief report: twin boys with major histocompatibility complex class II deficiency but inducible immune responses.

H M Wolf1, I Hauber, H Gulle, V Thon, H Eggenbauer, M B Fischer, S Fiala, M M Eibl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7990905     DOI： 10.1056/NEJM199501123320204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.

Authors:  Thomas Prod'homme; Benjamin Dekel; Giovanna Barbieri; Barbara Lisowska-Grospierre; Rina Katz; Dominique Charron; Catherine Alcaide-Loridan; Shimon Pollack
Journal:  Immunogenetics       Date:  2003-10-22       Impact factor: 2.846

2.  Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.

Authors:  I Hauber; H Gulle; H M Wolf; M Maris; H Eggenbauer; M M Eibl
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

3.  Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.

Authors:  J Douhan; I Hauber; M M Eibl; L H Glimcher
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.